Title

Development times, clinical testing, postmarket follow-up, and safety risks for the new drugs approved by the US food and drug administration: the class of 2008

Document Type

Response or Comment

Publication Date

1-2014

Journal

JAMA Internal Medicine

Volume

Volume 174, Issue 1

Inclusive Pages

90-95

Keywords

Clinical Trials as Topic--statistics & numerical data; Drug Approval--statistics & numerical data; Product Surveillance, Postmarketing--statistics & numerical data

Peer Reviewed

1